DNA Binding Irritants
Give this one a try later!
, Bendamustinea
Dactinomycin
Daunorubicin
Doxorubicin
Epirubicin
Idarubicin
Mechlorethamine
Mitomycin
Effective treatments for peripheral neuropathy
Give this one a try later!
Duloxetine
Gabapentin and Opioid Combination
Most sources recommend the application of heat using _______________ to help reduce
local discomfort and the restart of the peripheral IV in a larger vein (Polovich et al.,
2014).
Give this one a try later!
warm compress
Which of the following is a unique side effect that occurs with the agent oxaliplatin?
Give this one a try later!
, Cold sensory neuropathy
You realize that since Mrs. Turner is on a regimen that includes pertuzumab that she
should have her LVEF monitored every 6 weeks since she is receiving neoadjuvant
therapy. You review Mrs. Turner's most recent MUGA scan and see that her LVEF is
48%.
Give this one a try later!
Mrs. Turner's initial MUGA scan result was 55% and is now decreased to
48% which is a > 10% decrease in her LVEF. Per the prescribing information
for Perjeta, if the LVEF is 45%, or is 45% to 49% with a 10% or greater
absolute decrease below the pretreatment value, withhold PERJETA and
trastuzumab and repeat LVEF assessment within approximately 3 weeks
(http://www.gene.com/download/pdf/perjeta_prescribing.pdf). You should
call the doctor to provide the results of the MUGA scan compared to her
initial MUGA scan and anticipate that the trastuzumab and pertuzumab will
be held for this cycle of chemotherapy. Mrs. Turner should have a repeat
MUGA scan prior to cycle #4 and based on those results, discontinue
PERJETA and trastuzumab if the LVEF has not improved or has declined
further, unless the benefits for the individual patient outweigh the risks.
Which of the following medications is the likely cause of Mr. Rylan's constipation?
Give this one a try later!
Oncovin (vincristine) can cause neurotoxicity of the smooth muscle of the
GI tract which can lead to decreased peristalsis and paralytic ileus.
Constipation, abdominal pain, and paralytic ileus can be seen with
vincristine use.
Give this one a try later!
, Bendamustinea
Dactinomycin
Daunorubicin
Doxorubicin
Epirubicin
Idarubicin
Mechlorethamine
Mitomycin
Effective treatments for peripheral neuropathy
Give this one a try later!
Duloxetine
Gabapentin and Opioid Combination
Most sources recommend the application of heat using _______________ to help reduce
local discomfort and the restart of the peripheral IV in a larger vein (Polovich et al.,
2014).
Give this one a try later!
warm compress
Which of the following is a unique side effect that occurs with the agent oxaliplatin?
Give this one a try later!
, Cold sensory neuropathy
You realize that since Mrs. Turner is on a regimen that includes pertuzumab that she
should have her LVEF monitored every 6 weeks since she is receiving neoadjuvant
therapy. You review Mrs. Turner's most recent MUGA scan and see that her LVEF is
48%.
Give this one a try later!
Mrs. Turner's initial MUGA scan result was 55% and is now decreased to
48% which is a > 10% decrease in her LVEF. Per the prescribing information
for Perjeta, if the LVEF is 45%, or is 45% to 49% with a 10% or greater
absolute decrease below the pretreatment value, withhold PERJETA and
trastuzumab and repeat LVEF assessment within approximately 3 weeks
(http://www.gene.com/download/pdf/perjeta_prescribing.pdf). You should
call the doctor to provide the results of the MUGA scan compared to her
initial MUGA scan and anticipate that the trastuzumab and pertuzumab will
be held for this cycle of chemotherapy. Mrs. Turner should have a repeat
MUGA scan prior to cycle #4 and based on those results, discontinue
PERJETA and trastuzumab if the LVEF has not improved or has declined
further, unless the benefits for the individual patient outweigh the risks.
Which of the following medications is the likely cause of Mr. Rylan's constipation?
Give this one a try later!
Oncovin (vincristine) can cause neurotoxicity of the smooth muscle of the
GI tract which can lead to decreased peristalsis and paralytic ileus.
Constipation, abdominal pain, and paralytic ileus can be seen with
vincristine use.
